SC 13GCOAGCIK 0002114044
Hemab Therapeutics Holdings, Inc.
5%+ passive stake (SC 13G) filed .
Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent.
Filing facts
- Accession number
- 0000902664-26-003462
- Filer
- Hemab Therapeutics Holdings, Inc.
- Ticker
- COAG
- CIK
- 0002114044
- Form type
- SC 13G
- Form description
- 5%+ passive stake
- Filed at
- August 14, 2026
- Industry
- SIC 2836Biological Products
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/2114044/000090266426003462/0000902664-26-003462-index.htm ↗Filer's full EDGAR submission history
EDGAR · Hemab Therapeutics Holdings, Inc. (0002114044) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0000902664-26-003462.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.